Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts

por Samoszuk, Michael, Kanakubo, Emi, Chan, John K
Publicado 2005

Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

por Minor, David R., Moores, Samantha P., Chan, John K.
Publicado 2017

Human papillomavirus: The other invisible enemy

por Abel, Mary Kathryn, Huh, Warner K., Chan, John K.
Publicado 2020

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer

por Chan, John K., Lakomy, David S., McDonald, Yassmina, Kapp, Daniel S
Publicado 2020

Publication of oral and video presentations from the Society of Gynecologic Oncology annual meeting over 11 years – What characteristics were important?

por Milki, Anthony A., Cohen, Joshua G., Kaur Mann, Amandeep, Kapp, Daniel S., Chan, John K.
Publicado 2020

Progress and trends in publication of oral and video presentations at the society of gynecologic oncology annual meeting from 2006 to 2016

por Milki, Anthony A., Cohen, Joshua G., Mann, Amandeep Kaur, Kapp, Daniel S., Chan, John K.
Publicado 2021

IgG4-Related Disease

por Stone, John H., Chan, John K. C., Deshpande, Vikram, Okazaki, Kazuichi, Umehara, Hisanori, Zen, Yoh
Publicado 2013

Prevalence of Oral Human Papillomavirus Infection by Number of Vaccine Doses Among US Adults

por Abel, Mary Kathryn, Mann, Amandeep K, Sonawane, Kalyani, Kapp, Daniel S, Deshmukh, Ashish A, Chan, John K
Publicado 2021

Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?

por Chow, Stephanie, Wong, Deanna, Liao, Cheng-I, Mann, Amandeep, Tian, Chunqiao, Darcy, Kathleen M., Chan, John K.
Publicado 2020

Trends in Incidence of Cancers Associated With Obesity and Other Modifiable Risk Factors Among Women, 2001–2018

por Cotangco, Katherine R., Liao, Cheng-I, Eakin, Cortney M., Chan, Ava, Cohen, Joshua, Kapp, Daniel S., Chan, John K.
Publicado 2023

Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States

por Hsu, Chun-Hsiang, Chan, John K., Yin, Chun-Hao, Lee, Ching-Chih, Chern, Chyi-Uei, Liao, Cheng-I
Publicado 2019

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017

por Liao, Cheng-I., Francoeur, Alex Andrea, Kapp, Daniel S., Caesar, Michelle Ann P., Huh, Warner K., Chan, John K.
Publicado 2022

Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer

por Chan, John K., Liu, Jinan, Song, Jinlin, Xiang, Cheryl, Wu, Eric, Kalilani, Linda, Hurteau, Jean A., Thaker, Premal H.
Publicado 2023

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection

por Islamoglu, Hicret, Cao, Ruoqiong, Teskey, Garrett, Gyurjian, Karo, Lucar, Sebastian, Fraix, Marcel P., Sathananthan, Airani, Chan, John K., Venketaraman, Vishwanath
Publicado 2018

Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study

por Liao, Cheng-I, Caesar, Michelle Ann, Lee, Danny, Chan, Ava, Darcy, Kathleen M., Tian, Chunqiao, Kapp, Daniel S., Chan, John K.
Publicado 2022

Trends in Uterine Cancer Mortality in the United States: A 50-Year Population-Based Analysis

por Somasegar, Sahana, Bashi, Aya, Lang, Susan M., Liao, Cheng-I, Johnson, Caitlin, Darcy, Kathleen M., Tian, Chunqiao, Kapp, Daniel S., Chan, John K.
Publicado 2023

The Role of Diet Compared to Physical Activity on Women's Cancer Mortality: Results From the Third National Health and Nutrition Examination Survey

por Chan, Joshua E., Caesar, Michelle Ann, Mann, Amandeep K., Koh-Bell, Alex, Richardson, Michael T., Johnson, Caitlin R., Kapp, Daniel S., Chan, John K.
Publicado 2022

Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey

por Richardson, Michael T., Attwood, Kristopher, Smith, Gabriella, Liang, Su-Ying, LaVigne Mager, Katherine, Tewari, Krishnansu S., Coleman, Robert L., Kapp, Daniel S., Chan, John K., Monk, Bradley J.
Publicado 2023

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial

por Aghajanian, Carol, Swisher, Elizabeth M., Okamoto, Aikou, Steffensen, Karina Dahl, Bookman, Michael A., Fleming, Gini F., Friedlander, Michael, Moore, Kathleen N., Tewari, Krishnansu S., O’Malley, David M., Chan, John K., Ratajczak, Christine, Hashiba, Hideyuki, Wu, Meijing, Dinh, Minh H., Coleman, Robert L.
Publicado 2022

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG ran...

por Pitiyarachchi, Omali, Friedlander, Michael, Java, James J., Chan, John K., Armstrong, Deborah K., Markman, Maurie, Herzog, Thomas J., Monk, Bradley J., Backes, Floor, Alvarez Secord, Angeles, Bonebrake, Albert, Rose, Peter G., Tewari, Krishnansu S., Lentz, Samuel S., Geller, Melissa A., Copeland, Larry J., Mannel, Robert S.
Publicado 2022